These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8108596)

  • 21. [Changes in serum lipid levels and the spectrum of individual fatty acids in patients with chronic renal failure on conservative and hemodialysis treatment and their relation to dietary protein intake].
    Orbetsova V; Simeonov P; Todorov K; Elazarova F
    Vutr Boles; 1985; 24(4):63-70. PubMed ID: 4072171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dyslipidemia in patients being treated with peritoneal dialysis].
    Zharfbin A
    Vnitr Lek; 2006 Nov; 52(11):1051-7. PubMed ID: 17165524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of several factors that intervene in hemodialysis on serum levels of triglycerides and free fatty acids.
    Pérez-García A; Bretó M; Alvarińo J; Alegre B; Cruz JM
    Clin Nephrol; 1979 Jul; 12(1):14-7. PubMed ID: 477051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of heparin on the lipid level during hemodialysis].
    Nikolaeva NP; Siniukhin VN; Khokhlov AP; Iarmolinskiĭ IS; Stetsiuk EA
    Urol Nefrol (Mosk); 1990; (5):31-3. PubMed ID: 2264204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum lipoprotein (a) levels in maintenance hemodialysis patients.
    Okura Y; Saku K; Hirata K; Zhang B; Liu R; Ogahara S; Naito S; Kajiyama G; Arakawa K
    Nephron; 1993; 65(1):46-50. PubMed ID: 8413789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lipid behavior during hemodialysis using heparin and prostacyclin].
    Camici M; Evangelisti L
    Minerva Med; 1992 Dec; 83(12):801-4. PubMed ID: 1491759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
    Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
    Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of heparin in the changes of lipid patterns during a single hemodialysis.
    Teraoka J; Matsui N; Nakagawa S; Takeuchi J
    Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low molecular weight heparin: how does it modify lipid metabolism in chronic hemodialysis patients?].
    Schneider H; Schmitt Y
    Klin Wochenschr; 1991 Oct; 69(16):749-56. PubMed ID: 1662323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Niceritrol reduces plasma lipoprotein(a) levels in patients undergoing maintenance hemodialysis.
    Nakahama H; Nakanishi T; Uyama O; Sugita M; Miyazaki M; Yokokawa T; Okamura K; Tanaka Y; Shirai D
    Ren Fail; 1993; 15(2):189-93. PubMed ID: 8469786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
    Koslík S; Takác M
    Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic aspects of digoxin in patients with terminal renal failure III. Effect of heparin.
    van der Vijgh WJ; Oe PL
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):560-2. PubMed ID: 598950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of baoshen pill in treating chronic renal failure with long-term hemodialysis].
    Ji SM; Li LS; Ji DX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Feb; 13(2):71-3, 67. PubMed ID: 8334339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.
    Parra HJ; Mezdour H; Cachera C; Dracon M; Tacquet A; Fruchart JC
    Clin Chem; 1987 May; 33(5):721. PubMed ID: 2952378
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiences with minimal intermittent heparinization in chronic dialysis patients].
    Kovác A; Hünicke G; Bierwisch H
    Z Urol Nephrol; 1980 May; 73(5):353-9. PubMed ID: 7456802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation activation in extracorporeal hemodialysis.
    Camici M; Evangelisti L; Balestri P; Cioni L; Rindi P; Sagripanti A; Meriggioli M; Giordani R
    Int J Artif Organs; 1997 Mar; 20(3):163-5. PubMed ID: 9151152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-tern effect of hemodialysis without heparin on abnormal lipid metabolism in patients on regular dialysis treatment (author's transl)].
    Matsui N; Shinoda T; Akiba T; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1225-32. PubMed ID: 7328898
    [No Abstract]   [Full Text] [Related]  

  • 40. [Activity of lipoprotein lipase and the effect of heparin on the blood lipids pattern in exogenous obesity].
    Miturzyńska-Stryjecka H
    Pol Tyg Lek; 1967 Jan; 22(5):161-4. PubMed ID: 6038965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.